If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
INSULIN LISPRO MIX75/25 Versus HUMALOG® MIX75/25
When transitioning from Humalog® Mix75/25™ to Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™ KwikPen® (100 units/mL), no dose conversion is needed.
Do not perform dose conversion when transitioning to the generic LM75/25 3-mL Pen from Humalog Mix75/25 3-mL Pen.
For example, if a patient is transitioning from 20 units of Humalog Mix75/25, the patient would administer 20 units of generic LM75/25.
Generic LM75/25 is identical to Humalog Mix75/25 in terms of
3-mL Pen packaging.
Enclosed Prescribing Information
Generic = authorized generic
Humalog Mix75/25 = Humalog® Mix75/25 (insulin lispro protamine and insulin lispro injectable suspension)
Lilly = Eli Lilly and Company
LM75/25 = Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25™
NDC = National Drug Code
Pen = KwikPen®
Date of Last Review: February 23, 2020